Trials / Completed
CompletedNCT01002833
Comparison of Three Plasmodium Falciparum Isolates in an Experimental Human Malaria Infection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Plasmodium falciparum isolates display a wide genetic diversity with possibly different properties to induce immune responses. These properties could directly influence the ability to induce protective efficacy. Since 1998 an experimental human malaria infection model at the Radboud University Nijmegen Medical Center (RUNMC) has been very successful in answering questions with regards to immunological mechanisms of human Pf infection. To date only the NF54 strain of Pf has been deployed in this Nijmegen model. However, investigation of heterologous Pf challenge is not only highly informative for our basic understanding of induction of immune responses but also provides an essential model for protective capacity testing in the clinical development of candidate malaria vaccines. Recently, the parasite culture laboratory of the RUNMC has been able to overcome technical hurdles to produce infectious mosquitoes of two genetically different isolates from different geographical regions to increase the portfolio for Phase IIa trials. These isolates, PfA and PfB will be compared with the NF54 strain for parasitic, immunological and clinical features in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Exposure to Plasmodium falciparum infected mosquitoes | Healthy volunteers are exposed to the bites of 5 Plasmodium falciparum infected mosquitoes |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-10-27
- Last updated
- 2010-11-09
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01002833. Inclusion in this directory is not an endorsement.